Patents by Inventor Marilyn R. Carlson

Marilyn R. Carlson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230094778
    Abstract: Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
    Type: Application
    Filed: October 18, 2022
    Publication date: March 30, 2023
    Inventors: Marilyn R. CARLSON, Matthew J. D'ONOFRIO, David A. GONYER, Wayne ALVES
  • Patent number: 11517545
    Abstract: Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: December 6, 2022
    Assignee: EVOKE Pharma, Inc.
    Inventors: Marilyn R. Carlson, Matthew J. D'Onofrio, David A. Gonyer, Wayne Alves
  • Publication number: 20220151960
    Abstract: Nasal formulations of metoclopramide are administered for the treatment of symptoms associated with female gastroparesis. Also provided are methods of treating symptoms of female gastroparesis with nasal metoclopramide.
    Type: Application
    Filed: July 21, 2021
    Publication date: May 19, 2022
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Marilyn R. CARLSON
  • Publication number: 20200405666
    Abstract: Nasal formulations of metoclopramide are administered for the treatment of symptoms associated with female gastroparesis. Also provided are methods of treating symptoms of female gastroparesis with nasal metoclopramide.
    Type: Application
    Filed: June 22, 2018
    Publication date: December 31, 2020
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Marilyn R. CARLSON
  • Publication number: 20200276139
    Abstract: The present disclosure relates to methods of intranasal metoclopramide dosing.
    Type: Application
    Filed: September 10, 2018
    Publication date: September 3, 2020
    Inventors: Marilyn R. CARLSON, Wayne ALVES, Matthew J. D'ONOFRIO, David A. GONYER
  • Publication number: 20190388370
    Abstract: Nasal formulations of metoclopramide are administered for the treatment of symptoms associated with female gastroparesis. Also provided are methods of treating symptoms of female gastroparesis with nasal metoclopramide.
    Type: Application
    Filed: June 22, 2018
    Publication date: December 26, 2019
    Inventors: Matthew J. D'ONOFRIO, David A. GONYER, Marilyn R. CARLSON
  • Publication number: 20190328686
    Abstract: Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
    Type: Application
    Filed: December 13, 2017
    Publication date: October 31, 2019
    Inventors: Marilyn R. CARLSON, Matthew J. D'ONOFRIO, David A. GONYER, Wayne ALVES
  • Publication number: 20130316972
    Abstract: The invention provides methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes. The invention also provides diagnostic instruments and methods of diagnosing lactose intolerance using the diagnostic instruments.
    Type: Application
    Filed: January 17, 2013
    Publication date: November 28, 2013
    Applicant: Ritter Pharmaceuticals, Inc.
    Inventors: Andrew J. Ritter, Dennis Savaiano, Kristina A. Fitzgerald, Marilyn R. Carlson
  • Publication number: 20130217775
    Abstract: Nasal formulations of metoclopramide are administered for the treatment of symptoms associated with female gastroparesis. Also provided are methods of treating symptoms of female gastroparesis with nasal metoclopramide.
    Type: Application
    Filed: August 23, 2012
    Publication date: August 22, 2013
    Applicant: Evoke Pharma, Inc.
    Inventors: Matthew J. D'Onofrio, David A. Gonyer, Marilyn R. Carlson